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Up to date, tissue regeneration of large bone defects is a clinical challenge under exhaustive 
study. Nowadays, the most common clinical solutions concerning bone regeneration involve 
systems based on human or bovine tissues, which suffer from drawbacks like antigenicity, 
complex processing, low osteoinductivity, rapid resorption and minimal acceleration of tissue 
regeneration. This work thus addresses the development of nanofibrous synthetic scaffolds of 
polycaprolactone (PCL) - a long-term degradation polyester - compounded with 
hydroxyapatite (HA) and variable concentrations of ZnO as alternative solutions for 
accelerated bone tissue regeneration in applications requiring mid- and long-term resorption. 
In vitro cell response of human fetal osteoblasts as well as antibacterial activity against 
Staphylococcus aureus of PCL:HA:ZnO and PCL:ZnO scaffolds were here evaluated. 
Furthermore, the effect of ZnO nanostructures at different concentrations on in vitro 
degradation of PCL electrospun scaffolds was analyzed. The results proved that higher 
concentrations ZnO may induce early mineralization, as indicated by high alkaline 
phosphatase activity levels, cell proliferation assays and positive Alizarin-Red-S-stained 
calcium deposits. Moreover, all PCL:ZnO scaffolds particularly showed antibacterial activity 
against S. aureus which may be attributed to release of Zn
2+
 ions. Additionally, results here 
obtained showed a variable PCL degradation rate as a function of ZnO concentration. 
Therefore, this work suggests that our PCL:ZnO scaffolds may be promising and competitive 
short-, mid- and long-term resorption systems against current clinical solutions for bone tissue 
regeneration. 
  

















Large bone defects are still a clinical challenge. Up to date, defects caused by e.g. trauma, 
infection or tumor removal are usually treated either with autografts, allografts or xenografts 
[1–3]. However, donor-site morbidity related to autografts, high-costs of allografts, 
antigenicity and poor mechanical properties of natural grafts in addition to their complex 
manufacturing suggest that synthetic bone grafts provide a better solution [1–3].  Then, 
electrospun synthetic scaffolds of polycaprolactone (PCL) compounded with hydroxyapatite 
(HA) and zinc oxide (ZnO) emerge as promising alternatives against natural grafts. 
PCL is a semicrystalline polyester extensively studied, with an outstanding biocompatibility 
in vitro and in vivo [4,5]. Such features, in addition to the degradability of its ester bonds upon  
hydrolysis, turns PCL into a commonly used polymer in several devices approved by the U.S. 
Food and Drug Administration [6–8]. However, as this polymer lacks of specific cues for 
bone regeneration, further modifications are mandatory in order to optimize bone growth on 
PCL[9] . Given the flexibility of its chains at room temperature, its ability to be combined 
with multiple materials and its solubility in a large amount of organic solvents, PCL can be 
prepared for bone regeneration by means of combination with osteoactive materials followed 
by processing via electrospinning [10].  
Nanofibrous scaffolds obtained through electrospinning mimic the extracellular matrix of 
immature bone, which is characterized by randomly organized fibrous collagen structures 
with diameters ranging from 10 to 300 nm [11–13]. Considering that osteoblasts are adherent 
cells, it was reported that the topography of electrospun scaffolds promotes osteoblasts 
adhesion, migration and proliferation [11]. Such modification provides the physical cues for 














combination of PCL with osteoactive materials. HA is a ceramic with low degradability rate 
and high osteoconductivity caused by its resemblance with mineral components of natural 
bone matrix [14]. Many authors have previously reported the combination of PCL, polylactic 
acid (PLA) and polylactic-co-glycolic acid (PLGA) with HA as a coating or filler in bone 
tissue engineering (BTE) applications [15–17]. Likewise, ZnO promotes bone growth. 
However, its action mechanism is based on induction and acceleration of bone tissue 
regeneration in addition to active prevention of bacterial infections which may hinder tissue 
healing.  
ZnO is an inorganic material able to exert osteoinductive and osteoconductive effects. In 
particular, ZnO osteoinductivity was observed by Yusa et al on mesenchymal cells cultured 
on surfaces releasing Zn
2+
 ions [18]. These authors suggested that Zn
2+
 ions induce osteoblast 
differentiation by means of a significant increase of gene expression of col I (collagen I, most 
common protein of bone extracellular matrix), BMP-2 (bone morphogenetic protein, which 
induces mineralization of the extracellular matrix), alkaline phosphatase (biological marker of 
mineralization beginning), Runx2 (transcription factor that induces differentiation of 
mesenchymal cells into osteoblasts) and VEGF-A (angiogenic factor) [18].  
Furthermore, ZnO is widely recognized as an effective non-specific antibacterial agent against 
a broad spectrum of microorganisms [19]. Bacterial infections are among the commonest 
causes of bone graft failure [20–22]. Nowadays, mild infections are usually treated with 
antibiotics whereas advanced infections involve not only antibiotics but also graft removal, 
cleaning of the damaged area and implanting a new graft, thus exposing the patient to several 
surgeries which even increase re-infection risk of the treated tissue [23]. Moreover, frequent 
use of antibiotics implies higher risk for developing drug-resistant microorganisms like 














manufactured with materials functionalized with ZnO are promising alternatives to current 
antibacterial solutions.  
An ideal polymeric scaffold for BTE should not only be degradable but also its degradation 
time should match tissue regeneration time in order to guarantee the structural integrity until 
formation of new tissue. The latter physiological process normally requires between 2 and 6 
months (or even more) primarily depending on bone defect size [25]. Thus, time matching 
represents up to date a challenge concerning the design of degradable PCL scaffolds for BTE. 
PCL is slowly degraded under physiological conditions through deesterification by hydrolysis 
followed by phagocytosis when the molecular weight is below 3000 Da [26]. It has been 
reported that the total degradation of PCL homopolymer, depending on initial molecular 
weight, takes between 1 and 4 years, period of time that hinders the use of PCL at short- and 
mid-term applications concerning BTE [27]. Up to date, PCL degradation time was decreased 
either by copolymerization or mixture  with other lactones, polylactic acid and polyglycolic 
acid or by compounding of PCL with particles like hydroxyapatite, silicates and β-TCP 
(Tricalcium Phosphate) [27–30]. Although the latter technique have been already reported, 
the action mechanism of compounded particles on PCL degradation rate remains uncertain 
given that it is a function of multiple factors like chemical nature, particle size and polymer-
microenvironment interactions [31,32].  
Hence, this work addresses the synthesis via electrospinning of scaffolds of PCL compounded 
with HA and variable concentrations of ZnO for bone tissue engineering. In order to 
determine their suitability for bone tissue regeneration, in vitro response of human fetal 
osteoblasts cultured on different electrospun scaffolds is here evaluated. In addition, the 
antibacterial response of the scaffolds against Staphylococcus aureus is systematically 














in terms of nanostructured ZnO concentration as an alternative mechanism for regulation of 
PCL degradation rate. Degradation effects are analyzed by means of scanning electron 
microscopy, dynamic thermal analysis, mechanical properties, wettability and FTIR 
spectroscopy.  
2. MATERIALS AND METHODS 
2.1 Materials 
For scaffold fabrication, PCL (80000 Da) and ZnO nanopowder were purchased from Sigma 
Aldrich (Argentina). Bovine HA was kindly provided by Idear SRL (Argentina). Chloroform 
and dimethylformamide (DMF) were obtained from Sintorgan (Argentina). For in vitro 
evaluation of our scaffolds, human fetal osteoblast cell line (HFOb 1.19) was purchased from 
the Eucellbank (Barcelona, Spain). For cell culture, Dulbecco’s Modified Eagle’s Medium 
(DMEM), F-12, Fetal Bovine Serum (FBS) and L-Glutamine 200 mM were acquired from 
Lonza (Spain). Geneticin and Penicillin-Streptomycin 100x were provided by Sigma Aldrich 
(Spain). Antibacterial activity was evaluated against the gram-positive strain Staphylococcus 
aureus subsp. Aureus (ATCC® 25293™), kindly provided by Dr. Miguel Fernández de 
Ulivarri. Yeast extract, Peptone from Casein (pancreatic digest) and agar-agar were purchased 
from Neogen (Argentina). Glycerin and salts were acquired from Biopack (Argentina). All 
assays were performed under biosafety conditions level 2. 
2.2 Electrospinning of scaffolds 
For scaffold fabrication, a suspension of ZnO nanopowder was prepared in chloroform at a 
concentration of 8 %w/v. In order to obtain at final scaffolds a variable concentration of ZnO,   
different volumes of the suspension were mixed with DMF, keeping in all cases the ratio 
chloroform:DMF at 4:1 respectively. The mixtures were then homogenized and further 














The solutions thus obtained were separately loaded in 5 ml syringes and a high voltage of 8 
kV (High Voltage System, ALMA, Argentina) was applied. A positively charged jet was 
formed from the 22G syringe needle and nanofibers were sprayed onto a grounded aluminum 
film kept 15 cm away from the tip of the needle. Mats were dried for a week under room 
conditions. Table 1 summarizes the composition of the samples which were evaluated in this 
work.  
 
Table 1. Samples. Scaffolds prepared for further assessment of in vitro response and antibacterial activity. 
Polymer concentration is expressed in terms of %w/v respect to solution volume, whereas HA and ZnO 
concentrations are expressed in terms of wt% respect to polymer weight.   
 Sample Description 
 PCL 8 % w/V PCL 
With HA PCL:HA 
8 % w/V PCL 




8 % w/V PCL 
1 w% ZnO 
PCL:ZnO 3% 
8 % w/V PCL 
3 w% ZnO 
PCL:ZnO 6% 
8 % w/V PCL 
6 w% ZnO 
With HA and ZnO 
PCL:HA:ZnO 
1% 
8 % w/V PCL 
15 w% HA 
1 w% ZnO 
PCL:HA:ZnO 
3% 
8 % w/V PCL 
15 w% HA 
3 w% ZnO 
PCL:HA:ZnO 
6% 
8 % w/V PCL 
15 w% HA 
















2.3 Morphology study 
Morphology analysis as well as distribution of ZnO nanopowder within the fibers was 
performed through scanning electron microscopy (SEM). Samples were previously sputter 
coated with gold (JEOL JFC-1200, Japan) and further visualized with a Zeiss Supra 55VP 
(Carl Zeiss GmbH, Germany). Images were obtained using backscattered electrons at an 
accelerating voltage of 20 kV in order to analyze particle distribution within the fibers. SEM 
images were processed using the software Image J (National Institute of Health, United 
States). 
2.4 HFOb culture 
HFOb 1.19 (henceforth named HFOb) cells were cultured in 75 cm
2
 flasks using DMEM:F-12 
(1:1) containing 10% of FBS, 1% of Penicillin-Streptomycin, 0.9% of L-Glutamine and 0.6% 
of Geneticin. Cells were maintained in a humidified CO2 incubator, fed with fresh media after 
every 3 days and trypsinized using trypsin-EDTA for cell seeding experiments. HFOb of 
passages 4 to 6 were used during this study.  
For cell response evaluation, the scaffolds (Ø=13mm) previously described in table 1 were 
sterilized by immersion in ethanol 70% for 60 minutes and further rinsed with sterile PBS. 
Subsequently, such samples were immersed overnight in culture medium to promote cell 
adhesion. The scaffolds were then placed in 24-multiwell plates and irradiated with UV-light 




on each scaffold 
and on tissue culture polystyrene as control. 
2.5 Cell proliferation study 
Cell proliferation on different electrospun scaffolds was monitored after 3, 7 and 14 days by 
MTT assay (3-(4,5-methylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), employing the 














the tetrazolium salt in MTT reagent to produce soluble formazan dye that can be measured at 
570 nm. After desired periods, the cell-scaffold constructs were rinsed with PBS and 
incubated with 0.05% MTT reagent for 4 hours at 37°C, according to provider instructions. 
Formazan salts produced were then solubilized in SDS at 37°C for 18 hours. Finally, aliquots 
were pipetted into 96-multiwell plates and the samples were read using a microplate reader 
model TECAN Sunrise (Tecan Group Ltd, Switzerland).   
2.6 Determination of alkaline phosphatase activity  
Alkaline phosphatase (ALP) activity was spectrophotometrically measured by p-nitrophenyl 
phosphate (pNPP) method. ALP expression is an indicator of bone-forming ability of HFOb 
seeded on different scaffolds [33]. ALP catalyzes pNPP hydrolysis to produce inorganic 
phosphates and p-nitrophenol, which is detected  at 405 nm. Therefore, cells were cultured for 
3, 7 and 14 days and assessed for their ALP activity. Cell-scaffold constructs were washed 
with PBS, followed by addition of 10 mM pNPP (Sigma Aldrich, Spain) dissolved in buffer 
DEA and then incubated for 30 minutes at room temperature and under constant stirring. The 
reaction was stopped using 2N NaOH and aliquots were pippeted into 96-multiwell plates in 
order to measure absorbance at 405 nm using a microplate reader. Results were finally 
normalized with respect to the number of cells per well.  
2.7 Mineralization assay 
The dye Alizarin Red S (ARS) selectively binds to calcium salts and is widely used for 
calcium mineral histochemistry. During this study, detection and quantification of calcium 
deposits were then performed through ARS staining. Cell-scaffold constructs cultured for 14 
days were washed twice with PBS and later fixed with ethanol 70% for 60 minutes at 4°C. 
Subsequently, they were washed with distilled water, incubated with 40 mM ARS for 30 














ARS excess. The constructs were desorbed by incubating the samples in 10% acetic acid for 
30 minutes at room temperature under mild stirring. Supernatants and samples were then 
vortexed for 30 seconds and incubated at 85°C for 10 minutes. Supernatants were cooled 
down and centrifuged at 20000 g for 15 minutes. Finally, aliquots were pipetted into 96-
multiwell plates and absorbance was measured at 405 nm using a microplate reader. The 
background absorbance of the scaffolds caused by HA-content was determined by processing 
scaffolds without cells.  The final absorbance was then obtained by subtracting the 
background adsorption values. 
2.8 Antibacterial activity assessment 
For assessment of the antibacterial activity, a group of samples was further subjected to in 
vitro degradation by immersion in PBS at 37°C for 0 and 30 days. Samples were then rinsed 
with distilled water, dried at room temperature and subjected to microbiological evaluation. 
Samples degraded for 0 days were also microbiologically evaluated as a control. In all cases, 
each assay was repeated three times (n=3) by processing three replicates each assay (i=3). 
For evaluation of antibacterial response against Staphylococcus aureus, samples were cut 
(10x10 mm
2
), sterilized by immersion in ethanol 70% for 60 minutes, washed three times 
with sterile PBS and finally irradiated with UV-light for 15 minutes.  
In vitro antibacterial activity of our scaffolds against S. aureus was evaluated through a 
modified dilution method based on the standard CLSI M07-A9: Methods for dilution 
antimicrobial susceptibility tests for bacteria that grow aerobically (Cockeril et al. 2012). 
Firstly, S. aureus was cultured in Luria-Bertani-Miller (LBM) broth (10 g/l Casein Peptone, 5 
g/l Yeast extract and 10 g/l NaCl), incubated at 37°C for 16-18 hours and stored in LBM 
broth with 10% Glycerol. Before each assay, 5 ml of LBM broth were inoculated with 1x10
8
 














turbidity standard. Subsequently, the inocule was diluted in PBS  to obtain 5x10
5
 CFU/ml. 
Sterile samples were then immersed in 1 ml of inocule previously prepared and incubated for 
18 hours at 35±2°C. The survival colony forming units (CFU/ml) were determined by the 
plate count agar method in LBM. Final results were normalized with respect to the sample 
area and inoculation volume in order to express them as log CFU/cm
2
.  
2.9 Degradation assays 
The scaffolds were degraded and further assessed according to ISO 10993-13: Identification 
and quantification of degradation products from polymeric medical devices and further [34]. 
Samples were cut as rectangles ( 4 cm x 1 cm) and subsequently immersed in 20 mL of 
phosphate buffer saline (PBS, pH 7.4) and incubated at 37 °C for 5 and 15 days. Degradation 
medium was replaced by fresh PBS every 3 days. Finally, samples were rinsed with distilled 
water and dried at room temperature. A group of samples was further freezed-dried in order to 
quantify material wettability by means of contact angle.  
2.10 Mechanical properties  
Mechanical properties of samples after 0,5 and 15 days of degradation were determined 
through mechanical stress tests performed by a dual-column universal testing system model 
Instron-3369 equipped with a 5 kN load cell. Samples were cut as rectangles (45 mm x 10 
mm), clamped with an initial separation distance of 25 mm and the stress rate was set at 25 
mm/min. At least 5 specimens per samples were subjected to mechanical stress and their 
corresponding signals were analyzed using OriginPro software (MicroCal Software, Inc, 
United States). Young modulus, ultimate tensile strength and strain at fracture were 
determined.  














Wettability of samples was determined in terms of water contact angle measured according to 
the sessile drop method under room conditions by using a DSLR camera model Nikon D750 
equipped with a lens with a focal distance of 28 mm and 8 MP resolution.  PCL, PCL:HA, 
PCL:ZnO and PCL:HA:ZnO scaffolds with different ZnO contents and subjected to different 
incubation times in PBS (0, 5 and 15 days) were placed on a flat surface between the light 
source and the camera. 6 μL droplets of distilled water -according to ISO 55660-2- were 
pipetted on sample surface and pictures were recorded after 10 seconds [35]. Images were 
then pre-processed using Image J (National Institute of Health, United States)  and 
subsequently analyzed by SCA 20 software (Dataphysics Instruments, Germany).  At least 
three specimens per sample were evaluated.  
2.12 Differential Thermal Analysis 
Glass transition temperature of PCL is -60°C and its melting point is between 59 and 64°C, 
depending on crystallinity percentage [10]. Additives like fillers significantly affect material 
crystallization. Then, thermal behavior was evaluated through Differential Thermal Analysis 
(DTA). A DTA device model DTA-50 (Shimadzu, Japan) was used. Specimens weighing 5 
mg were heated up from room temperature to 150 °C at 20 °C/min and under nitrogen 
atmosphere at a constant flow of 20 mL/min.  Crystallization temperature (Tc) as well as 
melting temperature (Tm) were obtained from exothermic  and endothermic peaks 
respectively.  
2.13 Infrared spectroscopy 
In order to detect changes at functional groups of our scaffolds after degradation, Fourier 
Transform Infrared (FTIR) spectroscopy was accomplished. A FTIR device model Nicolet 
5700 (Thermo Nicolet, United States) equipped with DTGS detector and air purge system 














measure infrared transmission between 400 and 4000 cm
-1
. Spectra were obtained with 2 cm
-1
 
resolution and after 32 iterations. 
2.14 Statistical analysis 
Results are shown as mean±standard deviation. Variance analysis in all cases was done 
through Levene test with a significance level of 0.05. For mean values comparison (equal 
variance) of more than three data groups, One-Way ANOVA in combination with post hoc 
Tukey HSD test was applied. Direct comparison of two populations was performed through 
Student’s t-test for unpaired samples. For non-equal variances, Welch test for direct 
comparison of means was applied. Significance levels are reported at each assay.  
3. RESULTS 
3.1 Morphology study 
Nanofibrous topography of scaffolds plays a key role during initial regulation of cell adhesion 
and proliferation. Scaffolds morphology and particle distribution within fibers were studied 
through SEM, as it is shown in Figure 1. Cell response was evaluated against PCL and 
PCL:ZnO scaffolds containing 1, 3 and 6 wt% of ZnO with resulting fiber diameters of 
0.58±0.28 μm, 0.56±0.17 μm, 0.43±0.16 μm and 0.57±0.27 μm respectively. Scaffolds of 
PCL:HA and PCL:HA:ZnO 1, 3 and 6 % both compounded with 15 wt% HA were also 
assessed. In this case, fibers diameters were 0.53±0.21 μm, 0.57±0.23 μm, 0.77±0.22 μm and 
0.68±0.20 μm respectively. Higher contents of HA would lead to fragile structures and 
consequently, cracks. It must be noted that HA particles within the fibers are significantly 
larger than ZnO nanostructures and agglomerates. Furthermore, it can be seen that higher 
concentrations of ZnO nanopowder induce both higher amounts of ZnO agglomerates as well 
as larger ZnO agglomerates. Such effect is clearly visible at PCL:ZnO 6% scaffolds. Then, 














along the fibers strongly depends on ZnO nanopowder concentration. However, it is worth 
mentioning that fiber features are kept uniform showing only a significant increase of 
diameter for PCL:HA:ZnO 3 and 6% samples (p≤0.05). 
 
 
Figure 1 SEM with backscattered electrons. Micrographs of scaffolds with different ZnO contents. 
Magnification bars equal to 1 μm.  
 
3.2 Cell proliferation study 
HFOb proliferation was evaluated after 3, 7 and 14 days of culture on PCL, PCL:HA, 














PCL:HA:ZnO 1%, cell proliferation exponentially growths over time whereas on remaining 
samples, proliferation is constant from day 3 (PCL:ZnO 6%, PCL:HA:ZnO 3/6%) or from 
day 7 (PCL:HA, PCL:ZnO 1/3%) (p≤0.05). Additionally, it should be highlighted that the 
proliferation at day 14 on PCL samples is between 2 a 10 times larger than cell proliferation 
on PCL:HA, PCL:ZnO and PCL:HA:ZnO. Moreover, it is observed that higher concentrations 
of ZnO might induce lower cell proliferation. Hence, it is inferred that ZnO nanopowder 
addition might induce a decrease of cell proliferation. In addition, such effect seems to oppose 
PCL effect on HFOb proliferation. 
 
Figure 2 HFOb proliferation on scaffolds. HFOb proliferation on PCL, PCL:HA, PCL:ZnO 1, 3 and 6% 
and PCL:HA:ZnO 1, 3 and 6% determined by MTT assay. *Statistical significance against cell 
















3.3 Determination of alkaline phosphatase activity  
ALP is an enzyme that catalyzes the hydrolysis of extracellular phosphate esters towards 
inorganic phosphate, necessary for further synthesis and transport of vesicles to the bone 
extracellular microenvironment [36]. An increase of ALP activity correlated with a constant 
cell proliferation is a biomarker of mineralization initiation [36–38]. ALP activity of HFOb 
cultured for 3, 7 and 14 days on PCL, PCL:HA, PCL:ZnO and PCL:HA:ZnO is shown in 
Figure 3.  
  














1, 3 and 6% and PCL:HA:ZnO 1, 3 and 6% colorimetrically determined. *Statistical significance 
against ALP activity on PCL for the same period of culture (p≤0.05) (n=3, i=3). 
 
 
As observed, ALP activity exponentially increases over time from day 3 on PCL:ZnO 6%, 
PCL:HA:ZnO 3% and PCL:HA:ZnO 6% samples, reaching a maximum at day 14. On the 
contrary, ALP activity on remaining samples is either constant or decreases over time, except 
for the activity registered on PCL:ZnO 1%, which increases from day 7 (p≤0.05). At day 14 
of culture, ALP activity on PCL:ZnO 6% and PCL:HA:ZnO 3 and 6 % is 141, 107 y 86 times 
higher than the activity measured on PCL samples, respectively. It is worth mentioning that 
on samples with HA combined with ZnO, ALP activity does not increase in comparison to 
samples with only ZnO.  
Alkaline phosphatase activity results suggest an early initiation of mineralization on 
PCL:ZnO 6% and PCL:HA:ZnO 3 and 6% as well as a lack of or late mineralization on the 
other samples under study. Such results will be further discussed in following sections.  
3.4 Mineralization assay 
ARS staining was here used to quantify calcium deposits formed by HFOb cultured on 















Figure 4 Mineralization. Quantitative ARS staining of calcium deposits on PCL, PCL:HA, PCL:ZnO 1, 3 
and 6% and PCL:HA:ZnO 1, 3 and 6% at day 14 of culture.*Statistical significance against 
mineralization on PCL (p≤0.05) (n=2, i=3). 
 
As it can be observed, the absorbance values of eluents collected from PCL:ZnO 6% and 
PCL:HA:ZnO 6% are significantly higher than those related to remaining samples. At day 14 
of culture, mineralization on PCL:ZnO 6% and PCL:HA:ZnO 6% was found to be 27 y 30 
times higher in comparison to mineralization on PCL, respectively. A considerable lower 
mineralization is observed on the other tested samples, which supports the hypothesis claimed 
at the previous section regarding late mineralization on PCL, PCL:HA, PCL:ZnO 1/3% and 














3.5 Antibacterial activity assessment  
Antibacterial activity of the scaffolds towards S. aureus was evaluated following a modified 
dilution method based on a CLSI standard. Figure 5 shows the survival CFU after 18 hours of 
incubation at 35°C on samples with 0 and 30 days of degradation and as a function of ZnO 
concentration. 
 
Figure 5 Antibacterial activity of scaffolds. Log CFU/cm
2
 as a function of ZnO content for samples 
subjected to 0 and 30 days of in vitro degradation. * Statistical significance against PCL for the 
















As it can be observed in Figure 5, at day 0 of degradation, samples with ZnO induce a 
significant decrease of initial bacterial load in comparison to the negative control (p≤0.05). 
Particularly, higher concentrations of ZnO tend to induce antibacterial activity with higher 
intensity (p≤0.5). Also, it is worth mentioning that samples with HA and ZnO reduce the 
initial bacterial load as well, but their antibacterial activity does not show significant 
differences against samples containing ZnO (p≤0.05). Finally, it must be noted that although 
such significant differences were detected, the maximal reduction does not go over one order 
of magnitude in comparison to the negative control. It can be observed that such reduction is 
around 1000 times for PCL:ZnO 6%, which is equivalent to a decrease of 96% of bacterial 
load in comparison to the negative control. A similar behavior is observed at samples with 
HA and ZnO, among these PCL:HA:ZnO 1% reduces almost 99% of the initial bacterial load. 
Finally, it must be noticed  that after 0 and 30 days of degradation, on samples containing  HA 
and ZnO, higher amounts of ZnO induce a decrease of antibacterial activity in comparison to 
samples with only ZnO, contrary to the findings reported by other authors [39,40]. Such 
behavior suggests that polymer degradation after 30 days may counter ZnO antibacterial 
effect.  
3.6 Degradation assays: Morphology analysis 
SEM micrographs obtained with secondary electrons of the scaffolds after 0, 5 and 15 days of 
degradations are shown in figure 6. As it can be seen, degradation clearly induces morphology 
changes. Compared against PCL samples, which maintain their structural integrity after 15 
days under degradation, samples with ZnO and HA clearly show considerable structural 
modifications for the same period of time. Many cracks and notches can be seen at PCL:HA, 
PCL:ZnO and PCL:HA:ZnO after 15 days degradation. In particular, notches are mainly 














Degraded samples were dried, freeze-dried and subsequently weighed. After 15 days under 
degradation, the mass loss does not exceed 1% respect to initial mass (data not shown). 
Therefore, considering observed notches as well as the negligible mass loss and based on 













Figure 6 SEM of scaffolds with different degradation times. Micrographs of scaffolds with different ZnO content. PCL, PCL:HA, PCL:ZnO 1%, PCL:ZnO 3%, 
PCL:ZnO 6%, PCL:HA:ZnO 1%, PCL:HA:ZnO 3% and PCL:HA:ZnO 6%. Last row shows a zoom of samples after 15 days of degradation. 














3.7 Mechanical properties 
The assessment of mechanical properties of scaffolds before and after degradation is 
necessary to understand the degradation effects and also to elucidate the degradation 
mechanisms. Figure 7a presents typical stress-strain curves for PCL, PCL:HA, PCL:ZnO 3% 
and PCL:HA:ZnO 3% for 0, 5 and 15 days degradation. Figures 7b, 7c and 7d additionally 
show Young modulus, ultimate tensile strength and strain at fracture respectively for all 
samples.   
Analysis of mechanical properties at day 0 indicates that both ZnO as well as HA particles 
reinforce the scaffolds. Particularly, the ultimate tensile strength plot suggests that maximal 
reinforcement is given by PCL:ZnO 3% and PCL:HA:ZnO 3%. Further increase of ZnO 
content up to 6% contrarily exerts an opposite effect on material resistance. This might be due 
to the reagglomeration of ZnO nanoparticles, as it was observed at SEM micrographs with 
backscattered electrons, and its resulting loss of interaction with polymeric matrix [31].  
It can also be inferred from the bar plot shown in figure 7 that a marked decrease of 
mechanical properties is the main consequence of degradation advance. In particular, 
PCL:ZnO 3% and PCL:HA:ZnO 3% induce the greatest reduction of Young modulus (39% 
and 45% respectively), ultimate tensile strength (71% and 70%) and strain at fracture (76% 
and 84%) when compared against values at day 0 of degradation. In order to understand such 
response, the derivative of the ultimate tensile strength in function of time was obtained and 















Figure 7 Mechanical properties vs Degradation time. (a) Stress-strain curves of PCL, PCL:HA, 
PCL:ZnO 3% y PCL:HA:ZnO 3% (b) Young modulus (c) Ultimate tensile strength (d) Strain at 
fracture.  
 
First, these curves indicate that an increase of ZnO content up to 3% induces a significant 
increase of mechanical-resistance-loss rate. Second, curves show that the addition of HA 
particles also accelerates degradation. And third, curve shapes of PCL:ZnO 1 and 3%  suggest 
that degradation of such samples is presumably the result of  the combination of more than 

















Figure 8 Mechanical-resistance-loss rate. Derivative of ultimate tensile strength in function of 




Surface hydrophobicity in function of ZnO and HA content was evaluated in terms of contact 
angle between sample surfaces and distilled water. As it can be seen in figure 9, ZnO and HA 
addition does not significantly decrease samples wettability (Welch Test, p≤0.05). Regardless 
of the slight contact angle decrease observed after ZnO and HA addition, such difference 














particles might not be exposed on material surface so that they do not considerably affect 
intrinsic hydrophobicity of PCL.  
 
Figure 9 Wettability vs % ZnO. Contact angles between distilled water and sanples after 0 days of 
degradation. ** Statistical significance against PCL (p≤0.5).  
 
Contact angles at samples subjected to 5 and 15 days of degradation were also assessed. Such 
samples were dried and subsequently freeze-dried. In all cases, contact angle was equal to 0° 
(data not shown), which proves a significant increase of sample wettability caused by material 
degradation. Contact angle depends on chemical composition as well as solid-liquid 
interaction. The presence of surface polar groups induces a decrease of contact angle due to a 














indicate that scaffold degradation might induce exposure of polar groups which noticeably 
increase scaffolds wettability. 
3.9 Differential thermal analysis 
A first approach for crystallinity study of our scaffolds was accomplished through DTA. Such 
analysis was used in order to determine the influence of ZnO and HA as well as degradation 
effect on Tm, which represents an indirect measure of polymer cristallinity[43]. Such values 
were obtained from the first scanning during sample heating. Theoretically, through DTA is 
also possible to assess Tc behavior in function of aforementioned parameters. However, given 
technical features at room temperature of the available DTA equipment and considering that 
Tc of PCL is comparable to room temperature, it was not feasible to accurately register Tc 
given the shift introduced by the measurement system at that temperature range [42,44]. 
Figure 10 presents endothermal melting peaks of the scaffolds after 0 and 15 days of 
degradation as a function of ZnO and HA content. As it can be seen, curves at 0 days suggest 
that ZnO addition induces a decrease of Tm respect to Tm of pure PCL samples. Additionally, 
these curves also show that such decrease is greater when ZnO is combined with HA. 
Whereas for PCL:ZnO samples Tm reduction is approximately 2°C, for PCL:HA:ZnO 
samples such decrease is around 3°C. In both cases, such shift suggests that ZnO particles 
might hinder nucleation and subsequent growth of lamellaes, which leads to thinner lamellae 
and therefore Tm shifting according to other studies [31,42,45]. It is worth noting that the Tm 
shifts among scaffolds with different ZnO contents are similar. This might be due to a weak 
interaction between the polymer matrix and our fillers[31]. Furthermore, it is remarkable that 
whereas samples with ZnO induce Tm shifts, such effect is not registered with non-degraded 














nanoparticles -and therefore, low surface-volume ratio such particles might not considerably 
hinder matrix crystallization [31]. 
Figure 10 Differential thermal analysis. Melting temperature for samples (a,b,c) after 0 days of 
degradations and (d,e,f) after 15 days of degradation. 
 
Samples degradation, as it can be also observed in figure 10, results in Tm increase in all 
cases. As Eldsäter et al. reported, amorphous phase of PCL is degraded before crystalline 
phase degradation [44,46]. The most accepted theory claims that this effect is caused by rapid 
diffusion of water into amorphous regions, resulting in a relative increase of material 
crystallinity which is reflected in an increase of Tm -as our graphs show [42,46,47]. Finally, it 
must be noted that after degradation, significant differences between Tm of samples with ZnO 
and Tm of pure PCL samples practically disappear. Such phenomenon was also reported by 
Eldsäter et al. during abiotic degradation of PCL [46]. 














The hydrolytic degradation of our scaffolds was also assessed through FTIR. Figures 11 and 
12 present FTIR spectra for all samples at 0, 5 and 15 days under degradation between 4000-
1500 cm
-1
 and 1500-400 cm
-1
 respectively. Between 4000 and 1500 cm
-1
, degradation induces 
a lower intensity of bands at 2942 cm
-1
 and 2863 cm
-1
 in comparison to the same bands at 
non-degraded samples. Such bands are related to C-H bond in saturated carbon atoms, and 
therefore, decrease of band intensity implies chain scission and its resulting loss of saturated 
carbons [42,48–50]. Furthermore, it must be noted a wide band of low intensity between 1500 
and 1726 cm
-1
 in some degraded samples. Such band is related to C=O bond stretching at 
carboxyl groups and it is a consequence of PCL hydrolysis, which comprises an increase of 
terminal -COOH groups. This effect is also observed through an intensity increase at 1186-
1116 cm
-1
 bands, which is associated to C-O bonds at carboxyl groups[48]. Moreover, the 
peak observed at 1726 cm
-1
 corresponds to ester bonds stretching at the main polymer chain (-
CO) [42,48]. It is worth mentioning that whereas HA presence is clearly observed through 
bands at 569 cm
-1
 and 603 cm
-1
, caused by flexion of bonds at phosphate groups, ZnO signals 
are not registered given their low intensity. 
Finally, it must be pointed out that unlike other authors, new bands due to degradation are not 
observable e.g. at 3402 cm
-1
. This band is related to OH stretching of carboxyl group and is 
typically observed at hydrolyzed PCL [42].  Such lack of bands was also observed by Peña et 














Figure 11 FTIR spectrum 4000-1500 cm
-1
 for (a) PCL (d) PCL:HA (b,e,g) PCL:ZnO 
1, 3 and 6% y (c, f, h) PCL:HA:ZnO 1, 3 and 6% at 0, 5 and 15 days under 
degrdation.  
Figure 12 FTIR spectrum 1500-400 cm
-1
 for (a) PCL (d) PCL:HA (b,e,g) 
PCL:ZnO 1, 3 and 6% y (c, f, h) PCL:HA:ZnO 1, 3 and 6% at 0, 5 


















Among the several challenges imposed by BTE, the acceleration of bone tissue regeneration 
is so far an issue. PCL has been widely used in BTE given its low toxicity, its degradability 
through hydrolysis and its long-term mechanical stability [10]. However, this polymer lacks 
of specific cues for bone regeneration and therefore modifications are necessary in order to 
optimize bone growth on PCL [9]. As a first modification, in this work PCL was processed 
through electrospinning, a technique able to produce nanofibrous structures which mimic 
extracellular matrix of immature bone [11,12]. As it was shown in Figure 1, resulting 
membranes were composed by random fibers with diameters ranging from 400 to 500 nm. 
Moreover, PCL was here combined and electrospun with HA and ZnO, both osteoconductive 
materials which due to their brittleness, may not be used by themselves as scaffolds. In this 
study, scaffolds were assessed in function of the ZnO content. In vitro cultures of HFOb in 
contact with electrospun mats were subjected to cell proliferation assays, ALP activity  and 
ARS staining. Furthermore, antibacterial efficacy against S. aureus as well as in vitro 
degradation of our scaffolds in function of ZnO content were also here analyzed. 
Cell proliferation analysis in combination with ALP activity and mineralization results 
suggested not only that higher concentrations of ZnO induced higher mineralization but also 
demonstrated that ZnO may act as a triggering molecule for mineralization of the scaffolds. 
Furthermore, the results presented in this study also indicated that ZnO and HA might have 
opposite effects, as it will be further discussed. 
The main action mechanism of ZnO involves release of Zn
2+





 seems to exert an anabolic effect on osteoblastic cells at intra 
and extracellular level. Intracellularly, Zn
2+
 ions primarily regulates Runx2 expression, a 
transcription factor directly related to osteoblastic differentiation and bone maturation[18,53–
55]. In particular, Kwun et al demonstrated that Zn
2+
 deficiency delays the expression of 














extracellular level, the Zn
2+
 ion - a natural ALP co-factor - regulates the enzyme activity. The 
ALP is a dimer with very similar subunits. Each subunit (~69.000 Da) contains: (1) a Zn atom 
strongly bonded to a specific site, which contributes to structural integrity of the polypeptide; 
and (2) a Zn atom slightly bonded to the active site (Dean 2002). Thus, an increase of 
extracellular zinc induces an increase of ALP activity as Dean et al, Nagata et al and other 
authors already reported [57–61]. Therefore, the early triggering of mineralization inferred 
from the assays presented in this study as well as the increased amount of calcium deposits 
observed while  increasing ZnO concentrations may be due to intracellular and extracellular 
effects of Zn
2+
, respectively.  
Mineralization triggering involves three stages. At the beginning, there is an active cell 
proliferation which is almost simultaneously followed by extracellular matrix maturation 
during a second stage. Once cell proliferation rate decreases, ALP activity increases, reaching 
thus  a maximum of expression which consequently induces an optimization of extracellular 
matrix for subsequent mineralization, the third stage [36,62]. Owen et al further demonstrated 
that there is a reciprocal and functional relation between down-regulation of cell proliferation 
and osteoblastic differentiation [62]. Moreover, it must be considered that: (1) HA is 
minimally osteoinductive given its low solubility, in comparison to other calcium phosphates 
[14]; (2) HA exerts primarily an osteoconductive effect by increasing adhesion, migration and 
cell proliferation as well as promoting extracellular matrix maturation through increased 
expression of extracellular proteins like collagen and osteocalcin [63–66]; and (3) 
Zn
2+
primarily induces early mineralization, as it was already mentioned. Then, based on 
aforementioned facts, it may be inferred that simultaneous use of HA and ZnO involve the 
opposite effects. Such consequence was evidenced by the low cell proliferation measured at 
samples with both ZnO and HA. Furthermore, such result in addition to a clear higher 
mineralization observed on PCL:ZnO 6% indicates prevalence of Zn
2+
 effect over HA, which 














Regarding the microbiological assessment, the antibacterial activity of the scaffolds against S. 
aureus was evaluated by a modified dilution method based on CLSI standards. The results 
showed that scaffolds with ZnO both at 0 and 30 days of degradation have antibacterial 
activity against S. aureus. It was also shown the larger the ZnO content, the higher the 
antibacterial activity. In addition, the results suggest that the primary antibacterial action 
mechanism may be through release of Zn
2+
 ion, which seems to increase after 30 days of 
degradation. 
Up to date, three antibacterial action mechanisms of ZnO have been frequently reported: (1) 
cell membrane disruption after contact with nano ZnO; (2) release of Zn
2+
 ions and (3) 
production of reactive oxygen species (ROS) through photocatalysis [19,67,68]. The latter 
mechanism was not evaluated in this study since the samples were incubated without UV 
irradiation, which is mandatory for ROS induction. Considering then that the strain S. aureus 
is 71% more sensitive to Zn
2+
 action that to ZnO contact, and that the dilution method 
primarily depends on dilution of an antibacterial agent, it can be inferred that the antibacterial 
activity determined may be due to release of Zn
2+
 ions [19]. In addition, as Pasquet et al 
showed, the amount of ions released is increased in samples with larger concentrations of 
ZnO, which clearly explains the increase of activity detected with higher contents of ZnO 
within the scaffolds [19]. 
Finally, considering the degradation assays here performed, our results suggested that ZnO 
dispersion within the fibers plays a fundamental role during material degradation. As it was 
noted in figure 8, these curves first indicated that an increase of ZnO content up to 3% 
induces a significant increase of mechanical-resistance-loss rate. Second, these curves showed 
that the addition of HA particles also accelerates degradation. And third, curve shapes of 
PCL:ZnO 1 and 3%  suggested that degradation of such samples is presumably the result of  
the combination of more than one degradation mechanism. The first two points might be 














which act as stress concentrators. HA and ZnO particles might exert mechanical loads on 
polymer matrix leading then to hydrolysis acceleration, according to Díaz et al. and as it was 
observed by Augustine et al. at PCL scaffolds compounded with ZnO[28,42]. Regarding the 
third point, following facts must be considered: (1) Qu et al. demonstrated that ZnO acts as an 
external catalyst of polylactic acid (PLA) hydrolysis, an aliphatic polyester as PCL[69]; (2) 
Siparsky et al. proved that under autocatalysis or catalysis, degradation rate curve fits an 
exponential curve[70]; (3) given the low dissociation rate of terminal acid groups at PCL 
when compared against PLA, it is considered that autocatalysis at PCL practically does not 
occur[70]; (4) Vieira et al. showed that under non-catalyzed degradation conditions, ultimate 
tensile strength curves resembles the curves obtained during our assays[41]. Therefore, 
ultimate tensile strength curves and their derivatives suggest that both PCL:ZnO 1 and 3% as 
well as PCL:HA:ZnO 1 and 3% might be subjected to degradation as a result of combination 
of non-catalyzed hydrolysis of PCL and  catalyzed hydrolysis around ZnO particles. 
Moreover, given mechanical loads applied by particles themselves, degradation is also 
accelerated. Strikingly, at PCL:ZnO and PCL:HA:ZnO 6% samples, ZnO-catalyzed 
hydrolysis component seems significantly decreased. Given the reduction of effective 
polymer-ZnO contact surface due to the high amount of large agglomerates at such scaffolds, 
the curves suggest that catalyzed-hydrolysis might be decreased.  
 
5. CONCLUSIONS 
This study demonstrated that PCL:ZnO scaffolds are suitable for bone tissue engineering. In 
particular, it was shown that such scaffolds, with relatively low concentrations of ZnO, may 
accelerate bone tissue regeneration by the increase of ALP activity followed by early 
mineralization. Moreover, opposite effects of HA and ZnO was also showed. It was further 
demonstrated that the scaffolds exert an antibacterial effect on S. aureus. Such activity 














nanopowder not only significantly accelerates samples degradation but also suggest that 
degradation rate might be regulated through variation of ZnO nanopowder concentration  as 
well as through variation of ZnO dispersion within the fibers. Hence, it may be considered 
that the scaffolds here assessed are potentially suitable for BTE  given their osteoactive 
features, its antibacterial skills and their ability to be degraded in short-, mid- and long-term 
depending on ZnO content and dispersion. Therefore, the scaffolds here studied might be 
competitive products against the clinical solutions nowadays applied in regenerative medicine 
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 We synthesized electrospun PCL scaffolds compounded with ZnO nanostructures and 
hydroxyapatite  
 We evaluated the effect of the ZnO nanostructures and hydroxyapatite on the in vitro response 
of osteoblasts against our scaffolds as well as their antibacterial efficacy against S. aureus  
 We evaluated the in vitro degradation of our scaffolds in function of ZnO content  
 We demonstrated in vitro mineralization of our scaffolds as well as a significant antibacterial 
efficacy against S. aureus  
 We demonstrated the acceleration and regulation of the degradation rate of our scaffolds by 
compounding with ZnO nanostructures.  
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